IL22 and psoriasis: This is the first study to compare the therapeutic potential of intact and cytokine-preconditioned (IL-17, IL-22, and TNF-α) hUCB-MSCs and hUCB-MSC-Exo in a mouse model of IMQ-induced psoriasis-like skin inflammation.